You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neoadjuvant radiotherapy

Showing 1 - 25 of 8,183
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Implant Breast Reconstruction, Neoadjuvant Radiotherapy Trial in Wuhan (Neoadjuvant radiotherapy)

Recruiting
  • Breast Cancer
  • +2 more
  • Neoadjuvant radiotherapy
  • Wuhan, Hubei, China
    Xinhong Wu
Aug 8, 2023

Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • CapeOX + cetuximab
  • +2 more
  • (no location specified)
Sep 12, 2023

Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Jul 27, 2023

Soft Tissue Sarcoma, Adult Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma Trial in Lyon (radiation, other, procedure)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • Neoadjuvant RT
  • +3 more
  • Lyon, Rhône, France
    Centre Léon Bérard
Jan 12, 2023

Gene Signatures Searching of Sensitivity/Resistance to

Recruiting
  • Soft Tissue Sarcomas
  • pre-operative radiation
  • Standard surgery after rpreoprative radiation
  • Lyon, France
    Centre Léon Bérard
Feb 20, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Tianjin, China
  • +1 more
May 16, 2023

Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 5, 2023

Malignant Tumor of Lacrimal Drainage Structure Trial in Shanghai (Neoadjuvant Radiotherapy/Chemoradiotherapy Followed by

Recruiting
  • Malignant Tumor of Lacrimal Drainage Structure
  • Neoadjuvant Radiotherapy/Chemoradiotherapy Followed by Surgery
  • Surgery Followed by Adjuvant Radiotherapy/Chemoradiotherapy
  • Shanghai, China
    Fudan Eye & ENT Hospital
Mar 22, 2022

Locally Advanced Esophageal Carcinoma Trial in Nanjing (Neoadjuvant Chemotherapy, Neoadjuvant Toripalimab, Short Course

Recruiting
  • Locally Advanced Esophageal Carcinoma
  • Neoadjuvant Chemotherapy
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
Jun 21, 2022

Breast Cancer Trial (Neoadjuvant radiotherapy)

Not yet recruiting
  • Breast Cancer
  • Neoadjuvant radiotherapy
  • (no location specified)
Jan 31, 2022

Breast Cancer, Invasive Breast Cancer Trial in New York (diagnostic test, radiation, procedure)

Recruiting
  • Breast Cancer
  • Invasive Breast Cancer
  • Pre-neoadjuvant radiotherapy (NART) biopsy
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 31, 2023

Advanced Esophageal Squamous Cell Cancer Trial in Jinan (Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy)

Recruiting
  • Advanced Esophageal Squamous Cell Cancer
  • Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Apr 11, 2022

NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Yangzhou, Jiangsu, China
    People's hospital of northern jiangsu
Sep 26, 2023

Breast Tumors Trial in Shanghai (Neoadjuvant radiotherapy)

Recruiting
  • Breast Neoplasms
  • Neoadjuvant radiotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 28, 2022

Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative

Not yet recruiting
  • Brain Metastases
  • Radiotherapy
  • Preoperative Radiotherapy
  • +2 more
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
May 12, 2023

the Incidence of Complications Related to Rectal Anastomosis After Neoadjuvant Therapy Trial in Jinan (extended resection with

Recruiting
  • the Incidence of Complications Related to Rectal Anastomosis After Neoadjuvant Therapy
  • extended resection with splenic flexure mobilization
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Feb 23, 2022

Rectal Cancer by MRI-guided Radiotherapy

Not yet recruiting
  • Rectal Cancer
  • Radiotherapy with MRIdian with simultaneous integrated boost
  • Questionnaires before, during and after radiotherapy
  • (no location specified)
Jun 13, 2023

Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

Recruiting
  • Thymic Carcinoma
  • Envolizumab combined with radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 3, 2023

Rectal Cancer Trial in Bergen (On-couch adaptive radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • On-couch adaptive radiotherapy
  • Bergen, Norway
    Haukeland University Hospital
May 22, 2023

Rectal Cancer Trial in Krakow (Preoperative radiotherapy, Surgery)

Completed
  • Rectal Cancer
  • Preoperative radiotherapy
  • Surgery
  • Krakow, Malopolska, Poland
    1st Department of General Surgery
Jul 10, 2022

Neoadjuvant Chemo, PD-1 Antibody, Radiotherapy Trial (neoadjuvant chemo combined with PD-1 antibody + radical radiotherapy)

Not yet recruiting
  • Neoadjuvant Chemotherapy
  • +3 more
  • neoadjuvant chemotherapy combined with PD-1 antibody + radical radiotherapy
  • (no location specified)
Sep 21, 2022

Esophageal Cancer Trial (Hypofractionated radiotherapy)

Not yet recruiting
  • Esophageal Cancer
  • Hypofractionated radiotherapy
  • (no location specified)
Jan 18, 2023

Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal

Recruiting
  • Rectal Neoplasm
  • Reirradiation
  • Rome, Italy
    Fondazione Policlinico Gemelli
Aug 2, 2023

Breast Cancer Trial (Arm I (No PMRT), Arm II (PMRT))

Not yet recruiting
  • Breast Cancer
  • Arm I (No PMRT)
  • Arm II (PMRT)
  • (no location specified)
Aug 8, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

Active, not recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Jul 4, 2023